Eaton Vance Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $74.9M | Buy |
|
|||||
|
2022
Q2 | $85.8M | Buy |
|
|||||
|
2022
Q1 | $56.2M | Buy |
|
|||||
|
2021
Q4 | $44.8M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $41.1M | Buy |
|
|||||
|
2021
Q1 | $30.5M | Buy |
|
|||||
|
2020
Q4 | $30.2M | Sell |
|
|||||
|
2020
Q3 | $30.8M | Buy |
|
|||||
|
2020
Q2 | $25.1M | Buy |
|
|||||
|
2020
Q1 | $22.9M | Buy |
|
|||||
|
2019
Q4 | $24.2M | Sell |
|
|||||
|
2019
Q3 | $29.5M | Buy |
|
|||||
|
2019
Q2 | $24.8M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $24.3M | Sell |
|
|||||
|
2018
Q2 | $22.9M | Sell |
|
|||||
|
2018
Q1 | $25.3M | Sell |
|
|||||
|
2017
Q4 | $23.4M | Sell |
|
|||||
|
2017
Q3 | $24.6M | Sell |
|
|||||
|
2017
Q2 | $35.4M | Sell |
|
|||||
|
2017
Q1 | $51.2M | Buy |
|
|||||
|
2016
Q4 | $28.5M | Buy |
|
|||||
|
2016
Q3 | $30M | Buy |
|
|||||
|
2016
Q2 | $21.1M | Buy |
|
|||||
|
2016
Q1 | $2.92M | Hold |
|
|||||
|
2015
Q4 | $2.62M | Hold |
|
|||||
|
2015
Q3 | $2.35M | Buy |
|
|||||
|
2015
Q2 | $783K | Hold |
|
|||||
|
2015
Q1 | $784K | Hold |
|
|||||
|
2014
Q4 | $701K | Hold |
|
|||||
|
2014
Q3 | $562K | Hold |
|
|||||
|
2014
Q2 | $473K | Buy |
|